Valneva (NASDAQ:VALN) Shares Gap Up – Here’s What Happened

Valneva SE (NASDAQ:VALN)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $5.61, but opened at $6.21. Valneva shares last traded at $6.27, with a volume of 10,865 shares traded.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and set a $18.00 target price on shares of Valneva in a research report on Friday, January 31st.

Valneva Stock Performance

The company has a quick ratio of 2.25, a current ratio of 2.78 and a debt-to-equity ratio of 0.70. The firm has a 50 day moving average price of $4.52 and a two-hundred day moving average price of $5.66.

Institutional Trading of Valneva

A hedge fund recently bought a new stake in Valneva stock. ABC Arbitrage SA bought a new stake in Valneva SE (NASDAQ:VALN) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 19,244 shares of the company’s stock, valued at approximately $84,000. 11.39% of the stock is owned by hedge funds and other institutional investors.

Valneva Company Profile

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; IXCHIQ, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus; and VLA2001, an inactivated whole-virus COVID-19 vaccine.